BCEL
Atreca Inc
Price:  
0.15 
USD
Volume:  
655,684.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atreca Intrinsic Value

-13,797.93 %
Upside

Is Atreca undervalued or overvalued?

As of 2025-03-19, the Intrinsic Value of Atreca Inc (BCEL) is -20.55 USD. This Atreca valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.15 USD, the upside of Atreca Inc is -13,797.93%. This means that Atreca is overvalued by 13,797.93%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

0.15 USD
Stock Price
-20.55 USD
Intrinsic Value
Intrinsic Value Details

Atreca Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -20.55 - -20.55 -20.55 -13,797.93%
P/E (40.68) - (95.50) (65.54) -43796.4%
DDM - Stable (49.30) - (965.65) (507.48) -338416.8%
DDM - Multi (28.28) - (438.86) (53.55) -35797.9%

Atreca Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3.57
Beta 4.37
Outstanding shares (mil) 23.79
Enterprise Value (mil) -9.93
Market risk premium 4.60%
Cost of Equity 7.11%
Cost of Debt 5.00%
WACC 5.39%